Evaluation of Surfactant Protein B in the Differential Diagnostics of Dyspnea

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2010 by University Hospital Mannheim.
Recruitment status was Active, not recruiting

Sponsor:

Collaborator:

Roche Diagnostics AG, Switzerland

Information provided by:

University Hospital Mannheim

ClinicalTrials.gov Identifier:

NCT01197586

First received: September 8, 2010

Last updated: June 18, 2012

Last verified: September 2010

History of Changes

Tracking Information
First Received Date ^ICMJE	September 8, 2010
Last Updated Date	June 18, 2012
Start Date ^ICMJE	October 2010
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	Complete list of historical versions of study NCT01197586 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Evaluation of Surfactant Protein B in the Differential Diagnostics of Dyspnea
Official Title ^ICMJE	Not Provided
Brief Summary	Establishing new biochemical markers in the differential diagnostics and risk stratification in heterogeneous patient collectives is becoming more and more important. The markers should be objective, reliable, reproducible, quick and cost effective as well as specific and sensitive. Concerning the differential diagnostics of "dyspnea", NT-pro-BNP plays the most important role for the evaluation of a cardiac origin. However, a corresponding biochemical marker for pulmonary stress is lacking. The aim of the study at hand therefore was the evaluation of surfactant protein B in the differential diagnostics of pulmonary and cardiac diseases.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Cohort Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Probability Sample
Study Population	patients presenting with the symptom "dyspnea" in a university hospital emergency room
Condition ^ICMJE	Dyspnea Cardiac Disease Pulmonary Disease
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Active, not recruiting
Estimated Enrollment ^ICMJE	60
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: patients presenting with dyspnea and giving informed consent Exclusion Criteria: outpatients lack or doubt of legal competence indication for mechanical ventilation pregnancy palliative patients CPAP/LTOT BMI > 27 kg/m2 sepsis anemia dialysis
Gender	Both
Ages	50 Years to 80 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Germany

Administrative Information
NCT Number ^ICMJE	NCT01197586
Other Study ID Numbers ^ICMJE	2010_spb_ma
Has Data Monitoring Committee	Not Provided
Responsible Party	Dr. J. Saur, Universitaetsmedizin Mannheim
Study Sponsor ^ICMJE	University Hospital Mannheim
Collaborators ^ICMJE	Roche Diagnostics AG, Switzerland
Investigators ^ICMJE	Not Provided
Information Provided By	University Hospital Mannheim
Verification Date	September 2010
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top